Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
88
NCT04043338
Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 11, 2019
Completion: Apr 30, 2022
NCT04104399
Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects
Start: Oct 8, 2019
Completion: Mar 30, 2022